CRGX - cargo-tx.com Full Takeover Company Value

Graphic logo of CARGO Therapeutics, Inc (CRGX)

The management team led by Gina Qua Kim enjoys the support of major funds due to the skillful execution of research and development plans. CARGO Therapeutics (CRGX) bases its development of anti-tumor drugs on synergy with leading scientific centers. This price chart on GURU.Markets, where the Enterprise Value is , confirms the resilience of a business protected by complex patenting and strict FDA oversight.

CARGO Therapeutics (CRGX) - Total Company Value from 07/04/2022 to 11/01/2026

CARGO Therapeutics (CRGX) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price Performance Chart CARGO Therapeutics Inc.|CRGX - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization CARGO Therapeutics|CRGX - Real Price to Acquire Entire Company
- company book value details:
Equity per Share CARGO Therapeutics|CRGX - Company Book Value|Market-to-Book Ratio cargo-tx.com|CRGX - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Equity Ratio CARGO Therapeutics|CRGX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio cargo-tx.com|CRGX - Company Debts|Debts to Book Value CARGO Therapeutics|CRGX - Company Long-Term Debt|Company Short-Term Debt CARGO Therapeutics|Immediate Liquidity cargo-tx.com
- earnings and valuation multiples indicators:
CRGX - Net Profit
Analysis of all company metrics:CARGO Therapeutics
Flagship merchandise of CARGO Therapeutics, Inc.

Fundamental asset screening requires an analysis of the total enterprise value to eliminate market capitalization distortions. Enterprise value is calculated as the sum of the market price of shares and debt minus cash, which is critically important for CARGO Therapeutics (CRGX), as its high barriers to entry and patent protection for CAR-T therapy create significant intrinsic value in an acquisition scenario.

Competitors of CARGO Therapeutics (CRGX)

Value Adjusted for Debt and Cash LEGN|Sana Bio - Enterprise Value|Full Takeover Company Value Autolus Corp (AUTL)|ALLO (Allogene Therapeutics) - Real Price to Acquire Entire Company|Business Value RNAC|Total Company Value Cellectis SA|Total Enterprise Value Caribou Biosciences Inc. CRBU|Total Company Value Instil Bio, Inc (TIL)|genenta.com - Business Value|Enterprise Value IPSC (Century Therapeutics, Inc.)|JSPR - Real Price to Acquire Entire Company|SNTI - Total Company Value|Total Enterprise Value Adaptimmune|cero.bio (CERO) - Total Company Value|TCRT (Alaunos Therapeutics, Inc.) - Total Company Value|Total Company Value Achilles Therapeutics PLC|Total Enterprise Value poseida.com PSTX|Enterprise Value TSVT|Gracell Bio (GRCL) - Full Takeover Company Value